Filing Details

Accession Number:
0001606243-23-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-18 21:20:11
Reporting Period:
2023-12-14
Accepted Time:
2023-12-18 21:20:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626199 Alpine Immune Sciences Inc. ALPN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1606243 Paul James Rickey C/O Alpine Immune Sciences, Inc.
188 East Blaine Street, Suite 200
Seattle WA 98102
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-14 11,600 $5.02 11,600 No 4 M Direct
Common Stock Disposition 2023-12-14 11,600 $19.00 0 No 4 S Direct
Common Stock Acquisiton 2023-12-15 45,387 $5.02 45,387 No 4 M Direct
Common Stock Disposition 2023-12-15 45,387 $19.09 0 No 4 S Direct
Common Stock Acquisiton 2023-12-18 1,800 $5.02 1,800 No 4 M Direct
Common Stock Disposition 2023-12-18 1,800 $19.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy) Disposition 2023-12-14 11,600 $0.00 11,600 $5.02
Common Stock Stock Option (Right to buy) Disposition 2023-12-15 45,387 $0.00 45,387 $5.02
Common Stock Stock Option (Right to buy) Disposition 2023-12-18 1,800 $0.00 1,800 $5.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
62,935 2027-04-11 No 4 M Direct
17,548 2027-04-11 No 4 M Direct
15,748 2027-04-11 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2023.
  2. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. 100% of the shares underlying the option were fully vested as of April 1, 2021.